Abstract
DNA methylation, a DNA modification by adding methyl group to cytosine, has an important role in the regulation of gene expression. DNA methylation is known to be associated with gene transcription by interfering with DNA-binding proteins, such as transcription factors. DNA methylation is closely related to tumorigenesis, and the methylation state of some genes can be used as a biomarker for tumorigenesis. Aberrant DNA methylation of genomic regions, including CpG islands, CpG shores, and first exons, is related to the altered gene expression pattern characteristics of all human cancers. Subheading 1 surveys recent developments on DNA methylation and gene expressions in cancer. Then we provide analysis of DNA methylation and gene expression in 30 breast cancer cell lines representing different tumor phenotypes. This study conducted an integrated analysis to identify the relationship between DNA methylation in various genomic regions and expression levels of downstream genes, using MethylCapseq data (affinity purification followed by next-generation sequencing of eluted DNA) and Affymetrix gene expression microarray data. The goal of this study was to assess genome-wide methylation profiles associated with different molecular subtypes of human breast cancer (luminal, basal A, and basal B) and to comprehensively investigate the effect of DNA methylation on gene expression in breast cancer phenotypes. This showed that methylation of genomic regions near transcription start sites, CpG island, CpG shore, and first exon was strongly associated with gene repression, and the effects of the regions on gene expression patterns were different for different molecular subtypes of breast cancer. The results further indicated that aberrant methylation of specific genomic regions was significantly associated with different breast cancer subtypes.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Sproul D et al (2011) Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer. Proc Natl Acad Sci USA 108(11):4364–4369
Chen RZ et al (1998) DNA hypomethylation leads to elevated mutation rates. Nature 395(6697):89–93
Baylin SB et al (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72:141–196
Das PM, Singal R (2004) DNA methylation and cancer. J Clin Oncol 22:4632–4642
Baylln SB et al (1997) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72:141–196
Syeed N et al (2012) 5′-CpG island promoter hypermethylation of the CAV-1 gene in breast cancer patients of Kashmir. Asian Pac J Cancer Prev 13(1):371–375
Maeda K et al (2003) Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival. Oncol Rep 10:935–938
Yi J et al (2001) P16 gene methylation in colorectal cancers associated with Duke’s staging. World J Gastroenterol 7:722–725
Nakayama M et al (2004) GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer. J Cell Biochem 91(3):540–552
Jha AK et al (2012) Promoter hypermethylation of p73 and p53 genes in cervical cancer patients among north Indian population. Mol Biol Rep 39(9):9145–9157
Irizarry RA et al (2009) The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41(2):178–186
Brenet F et al (2011) DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS One 6(1):e14524
Li M et al (2009) Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer. BMC Med Genomics 2:34–46
Cancer Genome Atlas Research Network (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474(7353):609–615
Balch C et al (2010) Role of epigenomics in ovarian and endometrial cancers. Epigenomics 2(3):419–447
Neve RM et al (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10:515–527
Gautier L et al (2004) affy–-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20:307–315
Biomedical Informatics, The Ohio State University Medical Center. http://motif.bmi.ohio-state.edu/jinlab/BMI730/BMI730-10-Lecture10.ppt
Chae H, et al. (2011) mCpG-SNP-EXPRESS (methyl-CpG Single Nucleotide Polymorphism Gene EXPRESSion). http://biohealth.snu.ac.kr/mcpg-snp-express.
Feng J et al (2012) Identifying ChIP-seq enrichment using MACS. Nat Protoc 7(9):1728–1740
Rao X et al (2012) CpG island shore methylation regulates caveolin-1 expression in breast cancer. Oncogene. doi:10.1038/onc.2012.474
Warnes GR, et al. (2010). gplots: Various R programming tools for plotting data. R package version 2.8.0. http://CRAN.R-project.org/package=gplots
Acknowledgement
This work was supported by the Rural Development Administration(RDA), Next-Generation Information Computing Development Program, the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean Government (MEST) (No. 20120006013) and the Brain Korea 21 Project in 2012.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Lee, CJ., Evans, J., Kim, K., Chae, H., Kim, S. (2014). Determining the Effect of DNA Methylation on Gene Expression in Cancer Cells. In: Ochs, M. (eds) Gene Function Analysis. Methods in Molecular Biology, vol 1101. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-721-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-62703-721-1_9
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-720-4
Online ISBN: 978-1-62703-721-1
eBook Packages: Springer Protocols